Cost Effectiveness and Resource Allocation

Table 2 Mean changes from baseline (%)

From: A cost-utility analysis of pregabalin versus venlafaxine XR in the treatment of generalized anxiety disorder in Portugal

Week	Pregabalin			Venlafaxine XR
Week	Mean	SD	SE	Mean	SD	SE
1	−27.2	20.6	2.22	−18.7	20.2	2.08
2	−39.8	22.1	2.38	−34.7	24.3	2.51
3	−45.7	24.1	2.60	−43.0	24.9	2.56
4	−51.4	24.1	2.60	−48.3	25.9	2.67
5	−51.4	24.1	2.60	−48.3	25.9	2.67
6	−57.4	26.5	2.86	−51.5	26.0	2.69
7	−57.4	26.5	2.86	−51.5	26.0	2.69
8	−61.4	26.0	2.81	−52.6	26.0	2.68

Source: data on file.

Back to article page

ISSN: 1478-7547

Contact us

General enquiries: journalsubmissions@springernature.com